New England Journal of Medicine· Ronald R. Grunstein Virend K. Somers Ali Azarbarzin Atul Malhotra Scott A. Sands Brendan P. Lucey Sheryl E. Allen Kathryn Giblin Beverly L. Falcon So Young Park Jitong Lou and Kathryn Kruegerthe TRIUMPH-1-OSA and TRIUMPH-2-OSA Investigators*·· 7 hours agoPickScore69
Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
In brief
NEJM has published the full papers of TRIUMPH-OSA, two phase three trials of once-weekly retatrutide for obstructive sleep apnea. The authors are the investigator teams of the trials; detailed endpoint and safety data will be added once the full text becomes available.
Why it matters
The two OSA phase three trials appear together in NEJM, letting readers compare efficacy and safety of once-weekly retatrutide within one literature framework.
Source: New England Journal of Medicine · nejm.org